Kohei Ishimura

Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23

Satoshi Deyama, Kento Shimoda, Hiroe Suzuki et al. · Psychopharmacology · 2017 · 75 citations

Biochemistry, Functional Selectivity, Medicine +4

Design and Synthesis of Cyclopropane Congeners of Resolvin E2, an Endogenous Proresolving Lipid Mediator, as Its Stable Equivalents

Hayato Fukuda, Ryuta Muromoto, Yuuki Takakura et al. · Organic Letters · 2016 · 30 citations · Full text

Engineering, Organic Chemistry, Novel Anti-inflammatory Drugs +17

Design and Synthesis of Benzene Congeners of Resolvin E2, a Proresolving Lipid Mediator, as Its Stable Equivalents

Yuto Murakami, Hayato Fukuda, Ryuta Muromoto et al. · ACS Medicinal Chemistry Letters · 2020 · 23 citations · Full text

Resolvin E1, but not resolvins E2 and E3, promotes<scp>fMLF</scp>‐induced<scp>ROS</scp>generation in human neutrophils

Yuka Unno, Yoshinori Sato, Hayato Fukuda et al. · FEBS Letters · 2018 · 21 citations · Full text

Synthesis of Resolvin E3, a Proresolving Lipid Mediator, and Its Deoxy Derivatives: Identification of 18-Deoxy-resolvin E3 as a Potent Anti-Inflammatory Agent

Hayato Fukuda, Hiroyuki Ikeda, Ryuta Muromoto et al. · The Journal of Organic Chemistry · 2020 · 19 citations · Full text

Lipid Peroxidation, Immunology, Chemical Biology +20